BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Hadian Y, Fregoso D, Nguyen C, Bagood MD, Dahle SE, Gareau MG, Isseroff RR. Microbiome-skin-brain axis: A novel paradigm for cutaneous wounds. Wound Repair Regen 2020;28:282-92. [PMID: 32034844 DOI: 10.1111/wrr.12800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wallden M, Nijs J. Applying the understanding of central sensitization in practice. J Bodyw Mov Ther 2021;27:723-30. [PMID: 34391313 DOI: 10.1016/j.jbmt.2021.04.004] [Reference Citation Analysis]
3 Cheng W, Li J, Liu X. 5-Aminosalicylic acid for treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19351. [PMID: 32118774 DOI: 10.1097/MD.0000000000019351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats. European Journal of Pharmacology 2018;818:228-34. [DOI: 10.1016/j.ejphar.2017.10.056] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
5 Lee HS, Lee KJ. Alterations of Food-specific Serum IgG4 Titers to Common Food Antigens in Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil 2017;23:578-84. [PMID: 28992678 DOI: 10.5056/jnm17054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
6 Lee KN, Lee OY. The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract. 2016;2016:2031480. [PMID: 28115927 DOI: 10.1155/2016/2031480] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
7 Karakula-Juchnowicz H, Gałęcka M, Rog J, Bartnicka A, Łukaszewicz Z, Krukow P, Morylowska-Topolska J, Skonieczna-Zydecka K, Krajka T, Jonak K, Juchnowicz D. The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls. Nutrients 2018;10:E548. [PMID: 29710769 DOI: 10.3390/nu10050548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
8 Aerts L, Grangier L, Dallenbach P, Wenger J, Streuli I, Bianchi-demicheli F, Pluchino N. Understanding sexual pain in endometriosis. Minerva Ginecol 2019;71. [DOI: 10.23736/s0026-4784.19.04379-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
9 Gajula P, Quigley EM. Overlapping irritable bowel syndrome and inflammatory bowel disease. Minerva Gastroenterol Dietol 2019;65:107-15. [PMID: 30746927 DOI: 10.23736/S1121-421X.19.02559-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Viganò D, Zara F, Usai P. Irritable bowel syndrome and endometriosis: New insights for old diseases. Digestive and Liver Disease 2018;50:213-9. [DOI: 10.1016/j.dld.2017.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
11 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats. J Gastroenterol Hepatol. 2018;33:232-239. [PMID: 28440889 DOI: 10.1111/jgh.13808] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
12 Koloski N, Holtmann G, Talley NJ. Is there a causal link between psychological disorders and functional gastrointestinal disorders? Expert Rev Gastroenterol Hepatol 2020;14:1047-59. [PMID: 32715790 DOI: 10.1080/17474124.2020.1801414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Szałwińska P, Włodarczyk J, Spinelli A, Fichna J, Włodarczyk M. IBS-Symptoms in IBD Patients-Manifestation of Concomitant or Different Entities. J Clin Med 2020;10:E31. [PMID: 33374388 DOI: 10.3390/jcm10010031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Karatay E, Utku ÖG. Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome. Turk J Gastroenterol 2020;31:113-9. [PMID: 32141819 DOI: 10.5152/tjg.2020.19751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wu MC, Ma KS, Wang YH, Wei JC. Impact of tonsillectomy on irritable bowel syndrome: A nationwide population-based cohort study. PLoS One 2020;15:e0238242. [PMID: 32870916 DOI: 10.1371/journal.pone.0238242] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 García-Flores L, Santillán-Benítez JG, Cuevas-Yáñez E, Caballero-Vásquez P, Zamudio-Chávez S, Morales-Ávila E. Evaluation of the effect of 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol in comparison with metronidazole in an in vitro culture of Blastocystis in samples of patients with irritable bowel syndrome. J Parasit Dis 2019;43:506-12. [PMID: 31406417 DOI: 10.1007/s12639-019-01118-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Berg LK, Goll R, Fagerli E, Ludviksen JK, Fure H, Moen OS, Sørbye SW, Mollnes TE, Florholmen J. Intestinal inflammatory profile shows increase in a diversity of biomarkers in irritable bowel syndrome. Scand J Gastroenterol 2020;55:537-42. [PMID: 32329383 DOI: 10.1080/00365521.2020.1754455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Chabane H, Doyen V, Bienvenu F, Adel-patient K, Vitte J, Mariotte D, Bienvenu J. Les dosages d’IgG anti-aliments : méthodes et pertinence clinique des résultats. Position du groupe de travail de biologie de la Société française d’allergologie. Revue Française d'Allergologie 2018;58:334-57. [DOI: 10.1016/j.reval.2018.01.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
19 Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
20 Cheng L, Luo QQ, Chen SL. The role of intestinal mast cell infiltration in irritable bowel syndrome. J Dig Dis 2021;22:143-51. [PMID: 33511763 DOI: 10.1111/1751-2980.12971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zöller B, Ohlsson H, Waehrens R, Sundquist J, Sundquist K. Association of irritable bowel syndrome and venous thromboembolism. Scandinavian Journal of Gastroenterology 2018;53:784-9. [DOI: 10.1080/00365521.2018.1465118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Yamamoto M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics 2019;15:82. [PMID: 31111238 DOI: 10.1007/s11306-019-1543-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
23 Tse G, Lai ET, Yeo JM, Tse V, Wong SH. Mechanisms of Electrical Activation and Conduction in the Gastrointestinal System: Lessons from Cardiac Electrophysiology. Front Physiol 2016;7:182. [PMID: 27303305 DOI: 10.3389/fphys.2016.00182] [Cited by in Crossref: 15] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
24 Martinez-saez N, Fernandez-gomez B, Cai W, Uribarri J, del Castillo MD. In vitro formation of Maillard reaction products during simulated digestion of meal-resembling systems. Food Research International 2019;118:72-80. [DOI: 10.1016/j.foodres.2017.09.056] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
25 Burgess SL, Oka A, Liu B, Bolick DT, Oakland DN, Guerrant RL, Bartelt L. Intestinal parasitic infection alters bone marrow derived dendritic cell inflammatory cytokine production in response to bacterial endotoxin in a diet-dependent manner. PLoS Negl Trop Dis 2019;13:e0007515. [PMID: 31260452 DOI: 10.1371/journal.pntd.0007515] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
26 Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutr Res Pract 2021;15:411-30. [PMID: 34349876 DOI: 10.4162/nrp.2021.15.4.411] [Reference Citation Analysis]
27 Vignal C, Pichavant M, Alleman LY, Djouina M, Dingreville F, Perdrix E, Waxin C, Ouali Alami A, Gower-Rousseau C, Desreumaux P, Body-Malapel M. Effects of urban coarse particles inhalation on oxidative and inflammatory parameters in the mouse lung and colon. Part Fibre Toxicol 2017;14:46. [PMID: 29166940 DOI: 10.1186/s12989-017-0227-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
28 Salari-Moghaddam A, Keshteli AH, Esmaillzadeh A, Adibi P. Adherence to the pro-inflammatory diet in relation to prevalence of irritable bowel syndrome. Nutr J 2019;18:72. [PMID: 31711479 DOI: 10.1186/s12937-019-0487-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
29 Gomaa E, Ayoub MM. Vardenafil oral jellies as a potential approach for management of pediatric irritable bowel syndrome. Saudi Pharm J 2021;29:955-62. [PMID: 34588841 DOI: 10.1016/j.jsps.2021.07.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bao CH, Wang CY, Li GN, Yan YL, Wang D, Jin XM, Wu LY, Liu HR, Wang XM, Shi Z, Wu HG. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome. World J Gastroenterol 2019; 25(32): 4696-4714 [PMID: 31528095 DOI: 10.3748/wjg.v25.i32.4696] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
31 Cıralı C, Ulusoy E, Kume T, Arslan N. Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines. World J Pediatr 2018;14:448-53. [PMID: 29549607 DOI: 10.1007/s12519-018-0144-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis 2016;1:135-45. [PMID: 29922669 DOI: 10.1159/000447252] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 18.3] [Reference Citation Analysis]
33 Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol 2017; 23(37): 6788-6801 [PMID: 29085223 DOI: 10.3748/wjg.v23.i37.6788] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
34 Tse G, Lai ET, Lee AP, Yan BP, Wong SH. Electrophysiological Mechanisms of Gastrointestinal Arrhythmogenesis: Lessons from the Heart. Front Physiol 2016;7:230. [PMID: 27378939 DOI: 10.3389/fphys.2016.00230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
35 van Orten-Luiten AB, de Roos NM, Majait S, Witteman BJM, Witkamp RF. Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing. Cannabis Cannabinoid Res 2021. [PMID: 33998882 DOI: 10.1089/can.2020.0087] [Reference Citation Analysis]
36 Ji LJ, Li F, Zhao P, Weng LP, Wei J, Yan J, Liu LN. Silencing interleukin 1α underlies a novel inhibitory role of miR-181c-5p in alleviating low-grade inflammation of rats with irritable bowel syndrome. J Cell Biochem 2019;120:15268-79. [PMID: 31172560 DOI: 10.1002/jcb.28794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
37 Kvasnovsky CL, Leong LE, Choo JM, Abell GC, Papagrigoriadis S, Bruce KD, Rogers GB. Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study. European Journal of Gastroenterology & Hepatology 2018;30:107-12. [DOI: 10.1097/meg.0000000000000995] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
38 Ostrowska L, Wasiluk D, Lieners CFJ, Gałęcka M, Bartnicka A, Tveiten D. Igg Food Antibody Guided Elimination-Rotation Diet Was More Effective than FODMAP Diet and Control Diet in the Treatment of Women with Mixed IBS-Results from an Open Label Study. J Clin Med 2021;10:4317. [PMID: 34640335 DOI: 10.3390/jcm10194317] [Reference Citation Analysis]
39 Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis. 2016;1:135-145. [PMID: 29922669 DOI: 10.1159/000447252.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Nasef NA, Mehta S. Role of Inflammation in Pathophysiology of Colonic Disease: An Update. Int J Mol Sci 2020;21:E4748. [PMID: 32635383 DOI: 10.3390/ijms21134748] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
41 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
42 Roudsari NM, Lashgari NA, Momtaz S, Farzaei MH, Marques AM, Abdolghaffari AH. Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review. Daru 2019;27:755-80. [PMID: 31273572 DOI: 10.1007/s40199-019-00284-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
43 Chai Y, Lu Y, Yang L, Qiu J, Qin C, Zhang J, Zhang Y, Wang X, Qi G, Liu C, Zhang X, Li D, Zhu H. Identification and potential functions of tRNA-derived small RNAs (tsRNAs) in irritable bowel syndrome with diarrhea. Pharmacol Res 2021;173:105881. [PMID: 34509631 DOI: 10.1016/j.phrs.2021.105881] [Reference Citation Analysis]
44 Khalighi Sikaroudi M, Mokhtare M, Shidfar F, Janani L, Faghihi Kashani A, Masoodi M, Agah S, Dehnad A, Shidfar S. Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA/5-HT in patients with diarrhea-predominant irritable bowel syndrome: A randomized clinical trial. EXCLI J 2020;19:652-67. [PMID: 33013260 DOI: 10.17179/excli2020-2247] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
45 Dbar S, Akhmadullina O, Sabelnikova E, Belostotskiy N, Parfenov A, Bykova S, Bakharev S, Baulo E, Babanova A, Indeykina L, Kuzmina T, Kosacheva T, Spasenov A, Makarova A. Patients with functional bowel disorder have disaccharidase deficiency: A single-center study from Russia. World J Clin Cases 2021; 9(17): 4178-4187 [PMID: 34141780 DOI: 10.12998/wjcc.v9.i17.4178] [Reference Citation Analysis]
46 Mitselou A, Grammeniatis V, Varouktsi A, Papadatos SS, Klaroudas A, Katsanos K, Galani V. Immunohistochemical Study of Adhesion Molecules in Irritable Bowel Syndrome: A Comparison to Inflammatory Bowel Diseases. Adv Biomed Res 2021;10:21. [PMID: 34703800 DOI: 10.4103/abr.abr_2_20] [Reference Citation Analysis]
47 Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats: Metformin improves visceral pain. Journal of Gastroenterology and Hepatology 2019;34:186-93. [DOI: 10.1111/jgh.14367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
48 Filannino P, Di Cagno R, Vincentini O, Pinto D, Polo A, Maialetti F, Porrelli A, Gobbetti M. Nutrients Bioaccessibility and Anti-inflammatory Features of Fermented Bee Pollen: A Comprehensive Investigation. Front Microbiol 2021;12:622091. [PMID: 33603725 DOI: 10.3389/fmicb.2021.622091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Eslampour E, Ghanadi K, Aghamohammadi V, Kazemi AM, Mohammadi R, Vahid F, Abbasnezhad A. "Association between dietary inflammatory index (DII) and risk of irritable bowel syndrome: a case-control study". Nutr J 2021;20:60. [PMID: 34183016 DOI: 10.1186/s12937-021-00721-5] [Reference Citation Analysis]